TCM
CELG

Tekla Capital Management’s Celgene Corp CELG Stock Holding History

Tekla Capital Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-31,200
Closed -$3.08M – 163
2016
Q2 		$3.08M Buy
+31,200
New +$3.23M 0.13% 116
2015
Q4 		– Sell
-93,300
Closed -$10.1M – 170
2015
Q3 		$10.1M Buy
+93,300
New +$11.6M 0.36% 61
2014
Q4 		– Sell
-180,800
Closed -$17.1M – 120
2014
Q3 		$17.1M Buy
+180,800
New +$16.3M 0.8% 31

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Tekla Capital Management's CELG Position: Q4 2019 in Review

Tekla Capital Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 1,473,710 shares — an estimated $146M sold.

Tekla Capital Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $230M in Q1 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Tekla Capital Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Tekla Capital Management sold 1,473,710 Celgene Corp shares in Q4 2019, an estimated $146M.
  • Tekla Capital Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Tekla Capital Management's Celgene Corp position peaked at $230M in Q1 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Tekla Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.